DRUG OF ABUSE TESTS

AEI24 LABTEST has available to supply OEM for private label test kits for pharmaceutical and laboratory groups that want to create their own brand.

Having successfully completed the CE marking, available for use in Europe (CE)

Manufacturing company with CE, issued as OEM, in compliance with Directive 98/79EC of the European Parliament and of the council of in vitro diagnostic Medical devices, according to Annex III. ISO 13485 certification

PROFESSIONAL USE: As a way to determinate a physiological state of the patient;

MEDICAL USE: For medical therapeutically purposes.

DRUG ABUSE TESTS FOR THE OTC MARKET (CONSUMER)

This highly sensitive test system employs unique monoclonal antibodies to selectively identify methamphetamine and its metabolites in urine samples. This one-step test requires no additional instrumentation and results are easy to read.

Main advantages of our DOA

  • Qualitative results in 3-8 minutes;
  • No additional instrumentation or reagents required;
  • Great number of Drug Test combinations and cut offs available.

The One-Step Drugs of Abuse Multi-Test is a qualitative immunoassay for detecting the presence of drugs of abuse in urine samples.

Multipanel Screen 2,3,4,5,6,7,8,9,10,11,12 drugs (In Multipanel itself or with the Integrated cup).

Comply with the European Directive 2001/95/EC of the European Parliament on the general safety of products.

PRESENTATIONS AVAILABLE

SINGLE TEST IN STRIP AND CASSETTE FORMATS

DOA STRIPS

STRIPS IN BOXES OF 100 UNITS

Volume: 335ctnx5000pcs/ctn=1675,000pcs of DOA strip in a 20FC.

DOA CASSETTES

CASSETTES IN BOXES OF 25 UNITS

Volume: 335x1500pcs/ctn=502,500pcs of DOA cassette in a 20FC.

MULTI-DRUG PANEL FORMATS

DOA MULTIPANELS

MULTIPANELS OF 2, 5, 6, 7 AND 10 DRUG TEST PARAMETERS IN BOXES OF 20 UNITS

Volume: 270x1200pcs/ctn=324,000pcs of Multipanel in a 20FC.

DOA MULTIPANELS INTEGRATED CUP

MULTIPANELS IN BOXES OF 25 UNITS. UP TO 15 DRUG TEST PARAMETERS.

The Multidrug Rapid test is a rapid chromatographic immunoassay for
the qualitative detection of multiple drugs and drug metabolites in
urine at the following cut offs concentrations (Cut off levels):

LABTEST®+ is a registered trademark of A.E.I. 24 - LABTEST®+ © Copyright 2019